# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-25-107829
Filing Date
2025-11-06
Accepted
2025-11-06 16:59:01
Documents
60
Period of Report
2025-09-30

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | gpcr-20250930x10q.htm iXBRL | 10-Q | 2254147
2 | EX-10.1 | gpcr-20250930xex10d1.htm | EX-10.1 | 321937
3 | EX-10.2 | gpcr-20250930xex10d2.htm | EX-10.2 | 41417
4 | EX-31.1 | gpcr-20250930xex31d1.htm | EX-31.1 | 16146
5 | EX-31.2 | gpcr-20250930xex31d2.htm | EX-31.2 | 16243
6 | EX-32.1 | gpcr-20250930xex32d1.htm | EX-32.1 | 9850
7 | EX-32.2 | gpcr-20250930xex32d2.htm | EX-32.2 | 10137
8 | GRAPHIC | gpcr-20250930x10q001.jpg | GRAPHIC | 99035
| Complete submission text file | 0001104659-25-107829.txt |  | 8015408

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
9 | EX-101.SCH | gpcr-20250930.xsd | EX-101.SCH | 41172
10 | EX-101.CAL | gpcr-20250930_cal.xml | EX-101.CAL | 46096
11 | EX-101.DEF | gpcr-20250930_def.xml | EX-101.DEF | 179137
12 | EX-101.LAB | gpcr-20250930_lab.xml | EX-101.LAB | 363572
13 | EX-101.PRE | gpcr-20250930_pre.xml | EX-101.PRE | 260851
63 | EXTRACTED XBRL INSTANCE DOCUMENT | gpcr-20250930x10q_htm.xml | XML | 1137577

Mailing Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080
Business Address 601 GATEWAY BLVD SUITE 900 SOUTH SAN FRANCISCO CA 94080 (650) 457-1978
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 251459361
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)